FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

786260009: Product containing only oxybutynin in transdermal dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3771169017 Product containing only oxybutynin in transdermal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3771170016 Oxybutynin only product in transdermal dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only oxybutynin in transdermal dose form (medicinal product form) Has manufactured dose form Transdermal dose form (dose form) true Inferred relationship Some
Product containing only oxybutynin in transdermal dose form (medicinal product form) Is a Oxybutynin only product true Inferred relationship Some
Product containing only oxybutynin in transdermal dose form (medicinal product form) Is a Oxybutynin-containing product in transdermal dose form true Inferred relationship Some
Product containing only oxybutynin in transdermal dose form (medicinal product form) Count of base of active ingredient un false Inferred relationship Some
Product containing only oxybutynin in transdermal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Oxybutynin (substance) true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Is a True Product containing only oxybutynin in transdermal dose form (medicinal product form) Inferred relationship Some

Reference Sets

GB English

US English

Back to Start